Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoStart with Pro — $79/mo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Overseed Biotech raises €6.7 million in a Series A fundraising to become local manufacturer of 100% medical cannabis medicines

PRIVATEJul 04, 2024•about 2 years ago

Amount Raised

€6.7 Million

Round Type

Series A

OrléansBiotechnologyCannabis

Investors

Ui InvestissementAnthony Bourbon’s Blast.Club

Description

Orléans-based Overseed Biotech, specializing in agronomic research and the development of medicines derived from the cannabis plant, has announced a €6.7 million Series A fundraising. The funding will support the company's efforts to become the local manufacturer of 100% medical cannabis medicines, in preparation for the upcoming authorization of medical cannabis in France.

Company Information

Company

Overseed Biotech

Location

Orléans, Loiret, France

About

Overseed is the first French biotech company to obtain its license from the ANSM to start its R&D process on cannabis production for pharmaceutical purposes. We are a Biotech which combines leading expertise in genetics, agronomy, organic chemistry and pharma with the ambition to have an expert knowledge on the production of therapeutic cannabis. We will produce GACP and GMP certified dried flowers, full spectrum extracts and purified pharmaceutical grade active ingredients for laboratories. Overseed's research and experimentation will answer patients and the health industry expectations to guarantee production sovereignty, proximity of collaborations and certified quality of cultivated products, in direct connection with medical and scientific studies.

Related People

Suggested for you
1 contact

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Overseed Biotech's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching Overseed Biotech? See every signal — funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan